obesity-995x60.png obesity-995x60.png

FEATURED ARTICLES

Remote work, hybrid-GettyImages-2065627473 Can Your Team Coordinate The CRO Model You've Chosen?

Choosing the right CRO model matters less than a sponsor’s ability to coordinate it. Here’s how to match outsourcing strategy to internal capacity.

  • What Is IRT And How Does It Impact Clinical Trials?

    Automated randomisation, blind protection, and demand-driven supply handling replace envelope-based methods and paper-based tracking, changing study management from first site activation onward.

  • What Is Greenphire Travel For Clinical Trials?

    Travel logistics can drive patient dropout, and sites often absorb the burden. See how sponsor-funded, coordinator-led travel support for patients and caregivers reframes how retention is protected.

  • Engaged Patients, Better Data

    Automatically triggered micropayments tied to completed questionnaires connect patient-reported data collection with payment administration, aiming to support engagement while taking manual payment work off site staff.

WHITE PAPERS AND CASE STUDIES

SERVICES AND PRODUCTS

With over 40 years of expertise in cold chain management and a global network of trusted partnerships, we safeguard the integrity of your ultracold supply chain, providing real-time monitoring and assurance for dependable sample storage.

For over 35 years, Thermo Fisher Scientific has supported the clinical trial supply, distribution, and logistics needs of pharmaceutical and biotechnology sponsors globally.

At the center of every clinical trial is a patient waiting for a treatment to arrive safely, securely, and on time. Clinical trial supply services make that possible by ensuring investigational medicinal products (IMPs) are packaged, labeled, stored, and distributed in full regulatory compliance across global study sites

Explore the breadth of Altasciences’ expertise in clinical pharmacology studies, supporting regulatory submissions across a diverse range of therapeutic areas.

Managing clinical trial disclosure can be challenging with the ever-evolving regulatory landscape, and varying requirements across different jurisdictions and regulatory bodies. New and updated regulations need to be continuously monitored and assessed for potential impact on an organization, processes and overall strategy.

Ypsomed accelerates clinical progress by reducing barriers across clinical development, enabling earlier study readiness, greater visibility and more informed decisions.​

NEWS